George D. Kalliolias M.D. Ph.D.
George D. Kalliolias M.D. Ph.D.
Asst Professor, Weill Cornell Medical College, Asst Scientist, Hospital for Special Surgery
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα hss.edu
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
GD Kalliolias, LB Ivashkiv
Nature Reviews Rheumatology 12 (1), 49-62, 2016
4802016
Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins
L Wang, RA Gordon, L Huynh, X Su, KHP Min, J Han, JS Arthur, ...
Immunity 32 (4), 518-530, 2010
1322010
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis
PDA Issuree, T Maretzky, DR McIlwain, S Monette, X Qing, PA Lang, ...
The Journal of clinical investigation 123 (2), 928-932, 2013
1252013
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38
GD Kalliolias, LB Ivashkiv
The Journal of Immunology 180 (9), 6325-6333, 2008
1242008
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
GD Kalliolias, SN C Liossis
Expert opinion on investigational drugs 17 (3), 349-359, 2008
1182008
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
F Mizoguchi, K Slowikowski, K Wei, JL Marshall, DA Rao, SK Chang, ...
Nature communications 9 (1), 1-11, 2018
1142018
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages
A Triantafyllopoulou, CW Franzke, SV Seshan, G Perino, GD Kalliolias, ...
Proceedings of the National Academy of Sciences 107 (7), 3012-3017, 2010
1072010
Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial
GD Kalliolias, PE Georgiou, IA Antonopoulos, AP Andonopoulos, ...
Annals of the Rheumatic Diseases 66 (6), 842-843, 2007
1062007
Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts
A Lee, Y Qiao, G Grigoriev, J Chen, KH Park‐Min, SH Park, LB Ivashkiv, ...
Arthritis & Rheumatism 65 (4), 928-938, 2013
892013
Overview of the biology of type I interferons
GD Kalliolias, LB Ivashkiv
Arthritis research & therapy 12 (1), 1-9, 2010
802010
Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
GD Kalliolias, B Zhao, A Triantafyllopoulou, KH Park‐Min, LB Ivashkiv
Arthritis & Rheumatism: Official Journal of the American College of …, 2010
802010
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27
GD Kalliolias, RA Gordon, LB Ivashkiv
The Journal of Immunology 185 (11), 7047-7056, 2010
742010
Modulation of TNF-induced macrophage polarization by synovial fibroblasts
LT Donlin, A Jayatilleke, EG Giannopoulou, GD Kalliolias, LB Ivashkiv
The Journal of Immunology 193 (5), 2373-2383, 2014
722014
The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter‐regulated by …
RA Gordon, G Grigoriev, A Lee, GD Kalliolias, LB Ivashkiv
Arthritis & rheumatism 64 (10), 3119-3128, 2012
572012
Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease
G Yiannopoulos, V Pastromas, I Antonopoulos, G Katsiberis, G Kalliolias, ...
Rheumatology international 27 (4), 357-361, 2007
562007
Pharmacogenetic principles in the Hippocratic writings
GP Sykiotis, GD Kalliolias, AG Papavassiliou
The Journal of Clinical Pharmacology 45 (11), 1218-1220, 2005
512005
Prolonged tumor necrosis factor α primes fibroblast‐like synoviocytes in a gene‐specific manner by altering chromatin
C Sohn, A Lee, Y Qiao, K Loupasakis, LB Ivashkiv, GD Kalliolias
Arthritis & Rheumatology 67 (1), 86-95, 2015
432015
Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis
SD Chakravarty, PI Poulikakos, LB Ivashkiv, JE Salmon, GD Kalliolias
Clinical Immunology 148 (1), 66-78, 2013
412013
Effect of epoetin alfa therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy
G Iconomou, A Koutras, K Karaivazoglou, GD Kalliolias, ...
European journal of cancer care 17 (6), 535-541, 2008
312008
The impact of disease activity and tumor necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis
W HM, P N, L TJ, A A, K GD, Z YS, S F, N J, S L, Cunningham-Rundles S, ...
Clin Exp Immunol., 2016
222016
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20